Daily Archives: January 30, 2019

Inflammation in the liver provokes fibrosis but inflammation is also important for tumor surveillance. Inhibitors of chemokine pathways, such as CXCL16 and CXCR6 regulation of lymphocyte trafficking, are being tested as anti-fibrotic agents, but their … Continue reading →

Crohn’s disease (CD) is characterized by an imbalance of effector and regulatory T cells in the intestinal mucosa. The efficacy of anti-adhesion therapies led us to investigate whether impaired trafficking of T-regulatory (Treg) cells contributes to … Continue reading →

Alabama resident Andy Bolden spent much of the last five years on the couch, having difficulty doing something many people take for granted — breathing. Thanks to a lung transplant on Nov. 18, 2018, he can breathe normally again. It was a landmark for… Continue reading →

Around two-thirds of patients treated for breast cancer will have had hormone-sensitive tumors and, after their initial treatment, will be advised to undergo hormone therapy for five to 10 years to prevent recurrence. But around half of these patients … Continue reading →